Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39050
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Benedict, R. H. | - |
dc.contributor.author | Comi, G. | - |
dc.contributor.author | Oreja-Guevara, C. | - |
dc.contributor.author | Siva, A. | - |
dc.contributor.author | VAN WIJMEERSCH, Bart | - |
dc.contributor.author | Wiendl, H. | - |
dc.contributor.author | Buffels, R. | - |
dc.contributor.author | Kuenzel, T. | - |
dc.contributor.author | Vermersch, P. | - |
dc.date.accessioned | 2022-12-15T11:02:37Z | - |
dc.date.available | 2022-12-15T11:02:37Z | - |
dc.date.issued | 2022 | - |
dc.date.submitted | 2022-12-09T12:47:15Z | - |
dc.identifier.citation | Multiple Sclerosis Journal, 28 (S3) , p. 392 -393 | - |
dc.identifier.uri | http://hdl.handle.net/1942/39050 | - |
dc.description.sponsorship | Sponsored by F. Hoffmann-La Roche Ltd; writing and editorial assistance was provided by Articulate Science, UK. RHB Benedict has received research support from Biogen, Bristol Myers Squibb, F. Hoffmann-La Roche Ltd, Genzyme, Genentech, Novartis, National Institutes of Health, National Multiple Sclerosis Society and VeraSci; consultancy fees from Immunic Therapeutics, Latin American Committee for Treatment and Research in Multiple Sclerosis, Merck, Novartis, and Sanofi; speaking support from Biogen, Bristol Myers Squibb and EMD Serono; and royalties from Psychological Assessment Resources, Inc. | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.title | Cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data | - |
dc.type | Journal Contribution | - |
local.bibliographicCitation.conferencedate | OCT 26-28, 2022 | - |
local.bibliographicCitation.conferencename | 38th Congress of the | - |
local.bibliographicCitation.conferencename | European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis | - |
local.bibliographicCitation.conferenceplace | Amsterdam, NETHERLANDS | - |
dc.identifier.epage | 393 | - |
dc.identifier.issue | S3 | - |
dc.identifier.spage | 392 | - |
dc.identifier.volume | 28 | - |
local.format.pages | 2 | - |
local.bibliographicCitation.jcat | M | - |
local.publisher.place | 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
dc.identifier.isi | 000866540801374 | - |
local.provider.type | wosris | - |
local.description.affiliation | [Benedict, R. H.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY USA. | - |
local.description.affiliation | [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. | - |
local.description.affiliation | [Comi, G.] Casa Cura Policlin, Milan, Italy. | - |
local.description.affiliation | [Oreja-Guevara, C.] Hosp Clin San Carlos, Madrid, Spain. | - |
local.description.affiliation | [Siva, A.] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey. | - |
local.description.affiliation | [Van Wijmeersch, B.] Hasselt Univ, Univ MS Ctr, Pelt, Hasselt, Belgium. | - |
local.description.affiliation | [Wiendl, H.] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany. | - |
local.description.affiliation | [Buffels, R.; Kuenzel, T.] F Hoffmann La Roche Ltd, Basel, Switzerland. | - |
local.description.affiliation | [Vermersch, P.] Univ Lille, CHU Lille, INSERM, U1172,LilNCog,FHU Precise, Lille, France. | - |
local.uhasselt.international | yes | - |
item.fullcitation | Benedict, R. H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuenzel, T. & Vermersch, P. (2022) Cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data. In: Multiple Sclerosis Journal, 28 (S3) , p. 392 -393. | - |
item.contributor | Benedict, R. H. | - |
item.contributor | Comi, G. | - |
item.contributor | Oreja-Guevara, C. | - |
item.contributor | Siva, A. | - |
item.contributor | VAN WIJMEERSCH, Bart | - |
item.contributor | Wiendl, H. | - |
item.contributor | Buffels, R. | - |
item.contributor | Kuenzel, T. | - |
item.contributor | Vermersch, P. | - |
item.accessRights | Open Access | - |
item.fulltext | With Fulltext | - |
crisitem.journal.issn | 1352-4585 | - |
crisitem.journal.eissn | 1477-0970 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Cognitive improvements in ocrelizumab-treated.pdf | Published version | 4.46 MB | Adobe PDF | View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.